What is the Lyme disease epidemic ? / Health in English & Spanish with subtitles / en Inglés & Español con subtítulos

7 Apr 2024

Years of pain, paralysis and fear – without a diagnosis. For a long time, medicine seemed to ignore Lyme disease. The film accompanies several patients as they fight for an accurate diagnosis — and the right treatment.

Many Lyme disease patients suffer for a long time before receiving a diagnosis. Their symptoms, including pain and paralysis, often seem to indicate other diseases, like MS. The fact that they have been bitten by a tick that carried Lyme disease often only emerges after many examinations. This is exactly what happened to two of the film’s subjects: a girl from Brooklyn, NY and a researcher at Duke University. Both decided to take matters into their own hands and began carrying out independent research into their symptoms. Both ended up in the middle of a controversial medical debate and found themselves having to fight hard for adequate treatment.

7 Apr 2024

Años de dolores, parálisis y miedo: sin diagnóstico. La medicina ignoró durante mucho tiempo la enfermedad de Lyme. El reportaje acompaña a pacientes en su lucha por recibir un diagnóstico y tratamiento.

Muchos pacientes aquejados de la enfermedad de Lyme no saben durante mucho tiempo qué les pasa. Sus dolores y parálisis parecen apuntar a otras enfermedades, como la esclerosis múltiple. Solo después de muchos exámenes, suele descubrirse que el origen de sus síntomas está en una picadura de garrapata, causante de la enfermedad de Lyme. Es lo que le ocurrió a una chica de Brooklyn en Nueva York y a un investigador de la Universidad de Duke. Tuvieron que investigar sus síntomas ellos mismos, enredarse en un complicado debate médico y luchar para conseguir un tratamiento acertado.

Brain Injuries & the Havana Syndrome as consequence of a secret weapon / National Security & Health

Secret weapon that fires a high energy beam of microwaves or ultrasound

Havana Syndrome evidence suggests who may be responsible for mysterious brain injuries

1 Apr 2024

Efforts continue to investigate brain injuries suffered by U.S. officials. This is the fourth 60 Minutes Havana Syndrome report and, for the first time, there’s evidence of who might be responsible.

“60 Minutes” is the most successful television broadcast in history. Offering hard-hitting investigative reports, interviews, feature segments and profiles of people in the news, the broadcast began in 1968 and is still a hit, over 50 seasons later, regularly making Nielsen’s Top 10.

Three Fintech Stocks that might turn best picks / Trade & Investment

3 Attractive Fintech Stocks

Mar. 15, 2024 12:00 PM ET BSQKZ, PAGS, SQ, STNE / Steven Cress, Quant Team
SA Quant Strategist

This article reviews three fintech stocks with Strong Buy ratings, picking securities with the strongest collective value, growth, profitability, EPS Revisions, and price momentum vs. the sector.

Summary
Fintech is projected (by QED Investors) to reach $1.5 trillion (~20% CAGR) by 2030, driven by massive and rapid digital adoption within the traditional financial services industry.

Fintech growth is projected to be especially pronounced in the Latin American markets, led by Brazil and Mexico, at a CAGR of nearly 30% during the same time period.

Three payment processing and banking stocks, including two with primary markets in Brazil, and one U.S.-based giant looking to expand globally, top SA’s fintech Strong Buy list.

Woman using computer Laptop conducting online financial transactions through the internet. The concept of Mobile Banking or Virtual Banking technology that is convenient, emphasizing safety.
Sukanya Sonlila/iStock via Getty Images

Financials (XLF) are rallying as one of the top-performing sectors YTD and over the last 12 months, with shares of banks and other financial institutions capitalizing on AI trends. The technology boom with tailwinds from artificial intelligence has supercharged the markets, and Big Tech is driving major index gains over the past 12 months.

Big Tech 1Y Gains vs. The Rest
Big Tech 1Y Gains vs. The Rest (Bloomberg)

Global fintech revenue, per a QED Investors/Boston Consulting Group study, is projected to grow by a CAGR of over 20%, reaching $1.5 trillion by 2030, as disruptors continue penetrating the traditional financial services markets amid the banking industry’s digital adoption and transformation.

Global Fintech Boom

Fintech companies provide solutions and technologies that automate and enhance traditional financial activities for consumers and businesses. Fintech applications cover a wide range of areas, including mobile and in-store payment processing, online banking, trading, investing, and B2B transactions, to name a few. Global banking services revenue will reach $10.2 trillion by 2030, according to the BCG/QED study, and fintech’s share of the industry is projected to grow from 4% in 2021 to 13%. Despite massive growth in recent years, the study said, “The financial services industry remains fertile ground for disruption.” Moreover, fintech penetration of banking valuations will grow from 9% to 25%. The fintech sector in North America is expected to quadruple by 2030 from where it was in 2021, and Latin American markets are set to grow by a factor of 12.5x.

Fintech Market Boom
Fintech Market Forecast by Region (BCG Consulting)

This massive potential upside has been reflected in skyrocketing stock prices of major fintech companies. The ARK Fintech Innovation ETF (ARKF), which consists of nearly 40 fintech stocks, is up around 75% in the past year.

ARKF Fintech ETF 1Y Price Performance

ARKF vs. Market & Industry Benchmarks
ARKF vs. Market & Industry Benchmarks (SA Premium)

ARKF is heavily weighted, with the top 10 stocks accounting for over 60% of value and one stock, Coinbase (COIN), making up almost 15% of the portfolio. However, only two of the stocks in the fund are Quant-rated Strong Buys. In fact, only five among quant-rated stocks in the fintech payment processing industry are Strong Buys, two of which top SA’s best fintech stock list.

Best Fintech Stocks

Investors can find attractive fintech stocks to invest in, and at the right time, based on recommendations generated by SA’s quantitative stock rating system, which has a proven track record of strongly predicting future returns. SA Quant Ratings are based on over 100 underlying metrics that are systematically gathered, analyzed, and graded across five factors: Valuation, Growth, Profitability, Momentum, and EPS Revisions.

Two of the three stocks on the top fintech list have primary markets in Brazil, while the third, a U.S.-based giant, sees an opportunity for significant expansion internationally. All three of the SA Quant Team’s top fintech stocks have top marks in momentum and solid growth metrics. In addition to a Strong Buy Quant Ratings, the stocks have Buy ratings from SA and Wall Street Analysts.

Best Fintech Quant Metrics
Best Fintech Stocks Quant Ratings & Factor Grades (SA Premium)

Quant Rating: Strong Buy

Quant Sector Ranking (as of 3/14/24): 16 out of 693

Quant Industry Ranking (as of 3/14/24): 1 out of 43

Block, Inc, co-founded by Jack Dorsey, is the parent company of the Square business payment platform and mobile payment service Cash App. Block is #1 among SA quant-rated Transaction & Payment Processing Services stocks and #16 in the Financials sector. The stock surged 17% on February 23rd, after boosting full-year 2024 adjusted EBITDA guidance at the end of February. Block entered Strong Buy territory just recently on strong momentum, up 22% within the past three months. Block has indicated opportunities for significant growth, given the company has only a 5% share of a total addressable market of $205 billion ($130 billion for Square and $75 billion for Cash App). The total addressable market has grown 28% since 2020. Block, currently with over 90% of sales deriving from North America, sees a major opportunity to expand internationally. Chief Operating Officer Amrita Ahuja, in the Q423 call, said Block sees a “long runway for growth” outside the U.S.

Block Target Market Growth
SQ Target Market Growth (Block Investor Presentation)

The stock’s Strong Buy rating is heavily driven by favourable EPS revisions and forward growth metrics. Block has an astounding 33 earnings up revisions in the last three months to 4 down revisions.

SQ EPS Revisions
SQ Earnings Revisions (SA Premium)

According to consensus estimates, EPS is projected to grow 84% in FY24, 27% in FY25, and almost 30% in FY26. The consensus EPS target for the current fiscal year has been revised upward by 12% in 90 days and 37% in the past six months.

SQ Consensus EPS Estimates
SQ Consensus EPS Estimates (SA Premium)

The solid prospects are also key to Block’s A+ Growth Grade. Block’s forward EPS long-term (3-5 year CAGR) is +38%, 325% above the sector median of about 9%. Block’s forward EBITDA growth rate of +50% and operating cash flow growth forward of +162% are also impressive. Although its Valuation Grade is a C+, SQ has a solid forward PEG ratio of 0.62x, about 50% below the sector median.

    Quant Rating: Strong Buy

    Quant Sector Ranking (as of 3/14/24): 18 out of 693

    Quant Industry Ranking (as of 3/14/24): 2 out of 43

    PagSeguro Digital Ltd. provides financial technology solutions and services for consumers and businesses and is the second largest neobank in Brazil. PAGS, up ~70% in the past year, is soundly outperforming the S&P 500 (+34), the SPDR financial select sector index (+11%), and the median of quant-rated financial sector stocks (+1%), which is driving an A+ momentum grade.

    PAGS Stock vs. S&P 500 vs. XLF

    PAGS 1Y Price Performance
    PAGS 1Y Price Performance (SA Premium)

    PAGS posted an all-time high in annual net income in 2023 and, according to 2024 guidance, aims to grow total payment volume (TPV) by 12-16% after YoY growth of 21%. PAGS guided to net income growth of 16-22% in FY24. Q423 EPS of $0.33 beat by $0.03, and revenue of $874.3 million (YoY) beat by $30.1 million. According to consensus estimates, EPS is projected to grow 17% in FY24, and another 15% in FY25. PAGS has an impressive 11 up earnings revisions in the past 90 days, securing an ‘A’ Revisions Grade, which rose from a B in the wake of the February 28 earnings and guidance announcement.

    PAGS 2024 Guidance
    PagSeguro 2024 Guidance (PAGS Investor Presentation)

    PAGS long-term EPS growth forward, a heavily weighted quantitative metric, is 13%, and EBIT FWD is over 30%. PAGS forward PEG ratio is 0.76x, a 40% discount to the sector.

      Quant Rating: Strong Buy

      Quant Sector Ranking (as of 3/13/24): 67 out of 693

      Quant Industry Ranking (as of 3/13/24): 5 out of 43

      StoneCo. Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. STNE is up more than 100% in the past year, while the sector (XLF) is up 29% versus the S&P 500, +34%.

      STNE Stock vs. S&P 500 vs. XLF

      STNE 1Y Price Performance
      STNE 1Y Price Performance (SA Premium)

      STNE growth metrics crush the sector median. STNE’s forward EBIT growth rate is at 82% vs. a sector median of 3.8%, and forward EBITDA growth is 66%. STNE forward EPS Diluted Growth is 108%, and forward EPS Long-Term Growth is 62%.

      STNE Growth Grade
      STNE Growth Grade (SA Premium)

      STNE has 5 up revisions and 1 down revision in the past 90 days, with FY23 revenue projected to grow by 178% and 42% in FY24. Stone’s forward PEG ratio is also solid, carrying much weight behind its A- Valuation Grade. The forward PEG ratio of 0.29 is 77% below the sector median. STNE is both fast-growing and profitable with gross margins of 78%.

      SQ, PAGS, and STNE look like attractive investments, sitting at the top of the SA Quant Team’s list of quant-rated fintech stocks, showcasing solid profitable growth prospects according to quantitative factor grades and underlying metrics.

      Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

      I am Steven Cress, Head of Quantitative Strategies at Seeking Alpha. I manage the quant ratings and factor grades on stocks and ETFs in Seeking Alpha Premium. I also lead Alpha Picks, which selects the two most attractive stocks to buy each month, and also determines when to sell them.

      At the Oscar’s 2024 / Some Roasting, Gaffes & Annoying Moments

      Some Presenters & Speakers may need some training in effective communication skills.

      Jokes and comments pushing personal the limits in public.

      Is it a good idea to mention a person’s flaw, defect, weakness or make reference to an addiction problem when speaking in public and giving a presentation ?

      11 Mar 2024

      Jimmy Kimmel roasted Robert Downey Jr. and shared his love for Ryan Gosling in his opening monologue at the 96th Academy Awards, which aired Sunday on ABC.

      12 Mar 2024

      From fashion mishaps to hilarious moments, the 96th Academy Awards had it all! Celebrities found themselves in unexpected situations, like saying “My dress is broken!” Billie Eilish’s win and Emma Stone’s adorable confusion stole the show.

      And Jimmy Kimmel’s humour, including his compliments exchange with Trump, kept everyone entertained. But the laughs didn’t stop there. Kimmel kept the audience entertained with his witty jabs at the stars, including playful teasing of Robert De Niro and Jodie Foster. And when it came time for the big winners, like Oppenheimer and Robert Downey Jr., the celebrations were in full swing. But the party didn’t end with the ceremony.

      Stars rushed to change into their party outfits and headed straight for the Vanity Fair Oscar Party, where the glamour continued. From surprise appearances to jaw-dropping dresses, it was a night to remember. We saw stars like Chris Evans and Pamela Anderson making waves, while Sydney Sweeney’s dress brought back memories of Angelina Jolie’s iconic look. It was a night of glamour and laughter. Don’t miss out – watch now for an insider’s look at the magic of Hollywood’s most prestigious event!

      11 Mar 2024

      Al Pacino leaves the audience of the 2024 Oscars puzzled when he declines to list the 10 nominees for Best Picture before announcing Oppenheimer as the winner.

      11 Mar 2024

      Given that “Oppenheimer” the expected Best Picture winner, won, the 2024 Oscars ceremony left viewers pondering something else: What was up with Al Pacino?

      Milei being parodied at international TV

      8 Feb 2024

      Uno de los programas más vistos de la televisión israelí, Eretz Nehederet, presentó a un doble del presidente argentino, con su característica campera de cuero y el pelo largo.

      Diario Jornada, el portal de noticias líder en la Patagonia desde 1954. Más información y las últimas noticias en http://www.diariojornada.com.ar y en redes sociales como: JornadaWeb

      31 Oct 2023
      30 Oct 2023

      Esta burda imitación se suma a las burlas hechas por la TV estadunidense.

      Argentina’s President Javier Milei spoke about capitalism, socialism, and his economic principles In CPAC Speech / Bukele & Trump’s speeches

      24 Feb 2024

      At CPAC 2024, Argentina’s President Javier Milei spoke about capitalism, socialism, and his economic principles. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more.

      Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: https://account.forbes.com/membership…

      24 Feb 2024
      24 Feb 2024

      In remarks to CPAC, former President Trump resumed his mean impression of President Biden trying to get off a stage.

      Are covid mRNA vaccines safe ? / Health & Research

      22 Jan 2024

      Florida’s surgeon general recently called for a halt in Covid vaccines due to safety questions, while the federal government continues to heavily promote them for adults and kids alike. Today we begin with a little-told story about Covid vaccine injuries. It’s the story of Maddie, one of the children who took part in Pfizer’s vaccine study on children. It’s a remarkable account of what happened when Maddie got very, very sick, leading to accusations that Pfizer, the FDA, and the study leaders tried to bury her case.

      3 Jan 2024

      Florida Surgeon General Joseph Ladopo has called for a halt to the use of COVID-19 vaccines based on mRNA and said the vaccines could result in an illness.

      updated vaccine is designed to better protect against current variants / health, science & vaccination

      15th Nov 2023

      Did you know that the battle against RSV, a significant yet often overlooked respiratory virus, has recently seen groundbreaking advancements? Just a few months ago, the first-ever RSV vaccine was approved for individuals aged 60 and over, marking a monumental step in public health. Additionally, a new vaccine now offers protection for the most vulnerable among us – our babies.

      Ultimately, this will affect each and every one of us. Despite its severity, RSV remained largely under the radar until the COVID-19 pandemic brought it to the forefront as part of the “tripledemic” of COVID, Flu and RSV.

      As a scientist and doctor specializing in respiratory health, in this video, I try to shed light on RSV and these new vaccines…and hopefully convince you that this is a really big deal! So…let’s get into it. If you have any questions or other subjects (including TikTok videos!) that you’d like us to discuss, leave a comment below – we’d love to hear from you!

      13 September 2023

      As COVID cases rise across the U.S., people ages 6 months or older will now have access to an updated COVID vaccine to protect them against severe illness and death. The shots are expected to be available as soon as this week, according to the Centers for Disease Control and Prevention.

      The updated vaccine is designed to better protect against current variants. It was officially recommended Sept. 12 by both the CDC’s Advisory Committee on Immunization Practices and CDC Director Mandy Cohen.

      The Food and Drug Administration also endorsed the updated shot this week. The PBS NewsHour spoke with Dr. Payal Patel, an infectious disease physician at Intermountain Health in Utah, about what to know about the latest vaccine.

      Dr. Anthony Fauci’s admissions on the lab leak theory / mutant strain of COVID-19 that has a rapid death / Health & Science

      18th January 2024

      Chinese scientists are experimenting with a mutant strain of COVID-19 that has a rapid death rate and is 100 percent lethal to “humanized” mice. The study was shared last week from Beijing.

      A new investigation is reviving questions about what Beijing knew during the pandemic’s crucial early days. China’s population fell for a second year—a record decline of 2 million fewer people in 2023, coinciding with the COVID-19 pandemic.

      America’s deadly fentanyl crisis, plus China’s role in it, was highlighted by Secretary of State Antony Blinken at the annual World Economic Forum in Davos.

      11th January 2024

      Robby Soave delivers a radar on Dr. Anthony Fauci’s admissions on the lab leak theory.